Articles by : William Newton, Associate Editor/Senior Writer

House E&C GOP Leaders’ Draft Bill Would Exempt Sterile Generic Injectables from 340B Pricing Requirements

August 1, 2023 William Newton, Associate Editor/Senior Writer Views

House Energy & Commerce Committee's draft bill.

GOP leaders on the House Energy & Commerce Committee released a draft bill to address drug shortages that includes a provision that would exempt certain drug products from 340B pricing requirements.

Republican leaders of the U.S. House Energy and Commerce (E&C) Committee released a draft bill late last week that would [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

July 27, 2023 William Newton, Associate Editor/Senior Writer Views

Senate Finance Committee PBM reform bill markup.

The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.

The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Panel Seems to Be on Track To Vote Tomorrow on Bill With Language that 340B Providers Oppose

July 25, 2023 William Newton, Associate Editor/Senior Writer Views

Sens. Ron Wyden (left) and Mike Crapo's final revised PBM reform bill appears to retain language that 340B provider groups oppose.

The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

RWC-340B Backs Senate Bill That Would Let Ryan White Clinics Cover HIV Prevention Drugs and Services

July 25, 2023 William Newton, Associate Editor/Senior Writer Views

New U.S. Senate legislation would let Ryan White clinics voluntarily use federal grants for HIV prevention medications and associated services.

Ryan White Clinics for 340B Access (RWC-340B) last week praised a new bill in the U.S. Senate that would let [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B May Cause Providers to Buy More Expensive HIV Prevention Drugs, Conservative Policy Group Says

July 20, 2023 William Newton, Associate Editor/Senior Writer Views

The American Action Forum says in a new paper that 340B incentivizes providers to favor more expensive HIV medications, "raising costs for the rest of the health care system."

The 340B drug pricing program may incentivize hospitals and other covered entities to buy expensive preventative HIV medications over low-cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

July 20, 2023 William Newton, Associate Editor/Senior Writer Views

Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.

Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Panel Could Mark Up PBM Bill Next Week With Spread Pricing Language That 340B Providers Oppose

July 18, 2023 William Newton, Associate Editor/Senior Writer Views

A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.

The U.S. Senate Finance Committee could mark up a pharmacy benefit manager reform bill next week with Medicaid managed care [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

U.S. Chamber of Commerce Asks Court to Pause Medicare Drug Price Negotiations

July 18, 2023 William Newton, Associate Editor/Senior Writer Views

The U.S. Chamber of Commerce asked a federal district court last week for a preliminary injunction against Medicare drug price negotiation.

The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

July 13, 2023 William Newton, Associate Editor/Senior Writer Views

Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.

On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Adverse Appellate Rulings in Contract Pharmacy Cases Could Be “Truly Catastrophic,” 340B Health’s Testoni Says

July 11, 2023 William Newton, Associate Editor/Senior Writer Views

It could be “truly catastrophic” if two federal appeals courts rule as a third already has that drug makers do not have to deliver 340B drugs to multiple contract pharmacies, 340B Health President and CEO Maureen Testoni said at the 340B Coalition summer conference.

It could be “truly catastrophic” if two federal appeals courts rule as a third did in January that drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live